E-LIB Suche - Ergebnisse für: Gou, Hongfeng

1

Fisetin nanoparticles based on cells cycle and apoptosis in..:

Yang, Tingting ; Gou, Hongfeng ; Lin, Ting...
International Journal of Pharmaceutics. 654 (2024) - p. 123971 , 2024

Link: https://doi.org/10.1016/..

2

Dynamic ctDNA-based analysis of drug-resistant gene alterat..:

Zhou, Yu-Wen ; Zhao, Xin ; Ni, Lu...
International Immunopharmacology. 131 (2024) - p. 111887 , 2024

Link: https://doi.org/10.1016/..

3

Efficacy and biomarker analysis of second‐line nab‐paclitax..:

Li, Xiaofen ; Zhou, Nan ; Yang, Yu..
Cancer Science. , 2024

Link: https://doi.org/10.1111/..

4

68Ga-FAPI-04 positron emission tomography/CT and laparoscop..:

Zhang, Shunyu ; Hu, Qiancheng ; Chen, Xinchuan...
BMJ Open. 14 (2024) 4 - p. e075680 , 2024

Link: https://doi.org/10.1136/..

5

A Single-Arm Phase II Study of Nab-Paclitaxel Plus Gemcitab..:

Liu, Ting ; Li, Qing ; Lin, Zhen...
Cancer Research and Treatment. 56 (2024) 2 - p. 602-615 , 2024

Link: https://doi.org/10.4143/..

6

Sintilimab plus nab-paclitaxel as second-line treatment for..:

Zhou, Nan ; Li, Xiaofen ; Yang, Yu...
BMC Cancer. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

7

Pathological complete response to neoadjuvant tislelizumab ..:

Zhou, Nan ; Chen, Yuhong ; Huang, Qian...
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

8

Efficacy and safety of fruquintinib dose‐escalation strateg..:

Tan, Sirui ; Zhang, Shunyu ; Zhou, Nan...
Cancer Medicine. 12 (2023) 24 - p. 22038-22046 , 2023

Link: https://doi.org/10.1002/..

9

Identification of Immune Subtypes and Candidate mRNA Vaccin..:

Wei, Yuanfeng ; Zheng, Lingnan ; Yang, Xi...
The Oncologist. 28 (2023) 11 - p. e1052-e1064 , 2023

Link: https://doi.org/10.1093/..

10

Clinicopathological features of a rare cancer: Intrahepatic..:

Zheng, Lingnan ; Zhou, Nan ; Yang, Xi...
Clinics and Research in Hepatology and Gastroenterology. 47 (2023) 10 - p. 102244 , 2023

Link: https://doi.org/10.1016/..

11

Optimum duration of extended adjuvant endocrine therapy in ..:

Hu, Qiancheng ; Ye, Daoli ; Xudong, Zhao...
BMJ Open. 13 (2023) 4 - p. e070972 , 2023

Link: https://doi.org/10.1136/..

12

Medicine in Pancreatic Neuroendocrine Tumors (Well-Differen..:

, In: Tumor Therapeutic Regimens and Comprehensive Evaluation,

Gou, Hongfeng ; Long, Yu - p. 247-253 , 2023

Link: https://doi.org/10.1007/..

13

Local delivery of superagonist gene based on polymer nanopa..:

Hong, Zehua ; Zan, Xin ; Yu, Ting...
Chinese Chemical Letters. 34 (2023) 3 - p. 107603 , 2023

Link: https://doi.org/10.1016/..

14

Case report: Remarkable response to sintilimab, lenvatinib,..:

Zhou, Nan ; Lei, Chuan-Fen ; Tan, Si-Rui...
Frontiers in Pharmacology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

15

PD-1 inhibitors plus nab-paclitaxel-containing chemotherapy..:

Tan, Sirui ; Yu, Jing ; Huang, Qiyue..
Frontiers in Oncology. 12 (2022) - p. , 2022

Link: https://doi.org/10.3389/..